Z. Herrmann

785 total citations
11 papers, 408 citations indexed

About

Z. Herrmann is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Z. Herrmann has authored 11 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Hematology. Recurrent topics in Z. Herrmann's work include Bone health and treatments (8 papers), Medical Imaging and Pathology Studies (3 papers) and Peptidase Inhibition and Analysis (2 papers). Z. Herrmann is often cited by papers focused on Bone health and treatments (8 papers), Medical Imaging and Pathology Studies (3 papers) and Peptidase Inhibition and Analysis (2 papers). Z. Herrmann collaborates with scholars based in Germany, Austria and United Kingdom. Z. Herrmann's co-authors include D. Thiébaud, M. Tubiana-Hulin, Beat Thürlimann, Martin Pecherstorfer, C. Manegold, Michael Clemens, M. Degardin, E.U. Steinhauer, M Hrubisko and Charles R.J. Singer and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and British Journal of Cancer.

In The Last Decade

Z. Herrmann

11 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Z. Herrmann Germany 7 351 144 138 102 67 11 408
Joseph D. Kohles United States 11 244 0.7× 46 0.3× 121 0.9× 29 0.3× 66 1.0× 25 416
Melissa Pirolli United States 5 231 0.7× 74 0.5× 41 0.3× 29 0.3× 99 1.5× 16 365
John A. Kanis United Kingdom 5 191 0.5× 38 0.3× 93 0.7× 23 0.2× 67 1.0× 6 234
Jin Won Lee South Korea 8 150 0.4× 47 0.3× 5 0.0× 34 0.3× 139 2.1× 11 351
L. D. Castel United States 3 307 0.9× 128 0.9× 29 0.2× 12 0.1× 191 2.9× 8 362
P Ardissone Italy 6 238 0.7× 35 0.2× 186 1.3× 2 0.0× 188 2.8× 9 403
Y. Saïdi France 5 367 1.0× 34 0.2× 235 1.7× 2 0.0× 96 1.4× 8 439
Vlatko Pejša Croatia 10 75 0.2× 9 0.1× 13 0.1× 89 0.9× 15 0.2× 39 264
Jon Kotler United States 4 169 0.5× 204 1.4× 7 0.1× 8 0.1× 173 2.6× 5 300
Ceri Powell United Kingdom 11 119 0.3× 114 0.8× 5 0.0× 5 0.0× 106 1.6× 23 349

Countries citing papers authored by Z. Herrmann

Since Specialization
Citations

This map shows the geographic impact of Z. Herrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z. Herrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z. Herrmann more than expected).

Fields of papers citing papers by Z. Herrmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Z. Herrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z. Herrmann. The network helps show where Z. Herrmann may publish in the future.

Co-authorship network of co-authors of Z. Herrmann

This figure shows the co-authorship network connecting the top 25 collaborators of Z. Herrmann. A scholar is included among the top collaborators of Z. Herrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Z. Herrmann. Z. Herrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Obladen, Michael, Rolf F. Maier, Hugo Segerer, et al.. (2015). Efficacy and Safety of Recombinant Human Erythropoietin to Prevent the Anaemias of Prematurity. Contributions to nephrology. 88. 314–326. 4 indexed citations
2.
Herrmann, Z., et al.. (2003). The influence of renal function on NT-proBNP levels in various disease groups.. PubMed. 49(11-12). 649–56. 16 indexed citations
3.
Menssen, Hans D., A Fontana, Z. Herrmann, et al.. (2002). Effects of Long-Term Intravenous Ibandronate Therapy on Skeletal-Related Events, Survival, and Bone Resorption Markers in Patients With Advanced Multiple Myeloma. Journal of Clinical Oncology. 20(9). 2353–2359. 115 indexed citations
4.
Rizzoli, R., D. Thiébaud, Nigel Bundred, et al.. (1999). Serum Parathyroid Hormone-Related Protein Levels and Response to Bisphosphonate Treatment in Hypercalcemia of Malignancy. The Journal of Clinical Endocrinology & Metabolism. 84(10). 3545–3550. 32 indexed citations
5.
Herrmann, Z., et al.. (1999). The New Bisphosphonate Ibandronate in the Treatment of Tumor-Induced Hypercalcemia. Oncology Research and Treatment. 22(3). 208–211. 6 indexed citations
6.
Herrmann, Z., et al.. (1998). [Osteoporosis in multiple myeloma].. PubMed. 44(11). 649–53. 2 indexed citations
7.
Ralston, Stuart H., D. Thiébaud, Z. Herrmann, et al.. (1997). Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia. British Journal of Cancer. 75(2). 295–300. 91 indexed citations
8.
Pecherstorfer, Martin, Z. Herrmann, Jean‐Jacques Body, et al.. (1996). Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.. Journal of Clinical Oncology. 14(1). 268–276. 98 indexed citations
9.
Heim, Manfred, W. Queißer, Martin Pecherstorfer, et al.. (1995). Prospective Randomized Trial of Dichloromethylene Bisphosphonate (Clodronate) in Patients with Multiple Myeloma Requiring Treatment. A Multicenter Study. Oncology Research and Treatment. 18(5). 439–448. 37 indexed citations
10.
11.
Obladen, Michael, Rolf F. Maier, Z. Herrmann, et al.. (1990). 63 RECOMBINANT HUMAN ERYTHROPOIETIN (rhEPO) FOR PREVENTION OF ANAEMIAS OF PREMATURITY: A RANDOMIZED MULTICENTRE TRIAL. Pediatric Research. 28(3). 287–287. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph D. Kohles Breakdown of academic impact, for papers by Melissa Pirolli Breakdown of academic impact, for papers by John A. Kanis Breakdown of academic impact, for papers by Jin Won Lee Breakdown of academic impact, for papers by L. D. Castel Breakdown of academic impact, for papers by P Ardissone Breakdown of academic impact, for papers by Y. Saïdi Breakdown of academic impact, for papers by Vlatko Pejša Breakdown of academic impact, for papers by Jon Kotler Breakdown of academic impact, for papers by Ceri Powell
Rankless by CCL
2026